Minimally invasive adrenal surgery: Virtue or vice?

Jared Winoker, David T. Ahlborn, Olamide O. Omidele, Gustavo Fernandez-Ranvier, Ithaar H. Derweesh, Reza Mehrazin

Research output: Contribution to journalArticle

Abstract

Adrenocortical carcinoma (ACC) is a rare malignancy associated with poor prognosis despite available treatments. In patients with localized or locally advanced disease, complete resection with negative margins offers the only potential for cure. Unfortunately, most patients develop local and distant recurrence following initial resection highlighting the importance of meticulous surgical technique in the hands of an experienced surgeon. While minimally invasive surgery (MIS) has supplanted open surgery for small to medium-sized benign adrenal tumors, controversy surrounds the use of MIS for resection of ACC. We sought to provide an overview of the key oncological principles in the surgical management of ACC and to critically review the literature comparing outcomes between the open and MIS approaches.

Original languageEnglish (US)
Pages (from-to)267-276
Number of pages10
JournalFuture Oncology
Volume14
Issue number3
DOIs
StatePublished - Feb 1 2018
Externally publishedYes

    Fingerprint

Keywords

  • adrenal
  • adrenal cancer
  • adrenalectomy
  • adrenocortical carcinoma
  • laparoscopic adrenalectomy
  • minimally invasive surgery

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Winoker, J., Ahlborn, D. T., Omidele, O. O., Fernandez-Ranvier, G., Derweesh, I. H., & Mehrazin, R. (2018). Minimally invasive adrenal surgery: Virtue or vice? Future Oncology, 14(3), 267-276. https://doi.org/10.2217/fon-2017-0420